Venture capital is again wrestling with a familiar question, but with greater urgency in a higher-rate, lower-liquidity environment: what, exactly, is still financeable? A recent essay published by VC Cafe, titled “Is anything fundable anymore apart from deeptech?”, captures a growing anxiety among founders and investors that the market’s center of gravity has shifted sharply away from many consumer and software concepts that once attracted capital with relative ease.
The argument reflects a broader reassessment of risk that has been underway since public-market multiples reset and fundraising conditions tightened. In the years of abundant liquidity, venture investors could justify high valuations on the expectation of rapid growth and future exits. Now, with buyers more selective and IPO windows sporadic, investors are demanding clearer proof of durable demand, pricing power, and credible routes to profitability. The result is a more skeptical posture toward companies that depend on aggressive user acquisition, heavy subsidization, or business models whose economics only work at massive scale.
Against that backdrop, deeptech’s appeal has strengthened. In the VC Cafe piece, the question is framed less as a proclamation that only deeptech can get funded and more as a provocation: if sophisticated software products, marketplaces, and many direct-to-consumer plays are struggling to raise capital on reasonable terms, what categories still inspire conviction? Deeptech offers a narrative that can fit the moment. Its products often address strategic needs such as energy resilience, industrial automation, advanced materials, defense, and applied AI in regulated or mission-critical settings. Many of these areas are aligned with government priorities and corporate spending that is less discretionary than consumer demand.
Investors also increasingly value defensibility. In an era where foundational AI capabilities are widely accessible and incremental software feature sets can be replicated quickly, companies that can protect an advantage through proprietary data, specialized hardware, scientific expertise, or regulatory moats stand out. Deeptech businesses, while riskier in terms of R&D timelines, can offer precisely that kind of insulation from fast-follow competition.
There is, however, a tension at the heart of the current deeptech enthusiasm. These startups frequently require larger checks, longer holding periods, and more patient capital than traditional software-as-a-service companies. They also tend to be exposed to manufacturing scale-up risk, supply-chain constraints, certification hurdles, and dependency on a small number of early customers. For generalist funds accustomed to shorter paths to product-market fit, that reality can be a mismatch, even if the thematic interest is genuine.
The shift in investor preference is also being felt unevenly across geographies. In Europe, where VC funds have historically been smaller than their U.S. counterparts and late-stage capital shallower, the push toward deeptech can be both an opportunity and a constraint. It plays to European strengths in research institutions and engineering talent, yet it also intensifies the need for financing structures capable of supporting capital-intensive growth. That increases the importance of corporate partnerships, public funding, and specialized investment platforms that can underwrite longer development cycles.
For founders outside deeptech, the message is not necessarily that funding has vanished, but that the burden of proof has risen. More rounds are taking longer, with more investors requiring evidence of repeatable sales, disciplined spending, and realistic unit economics. Companies that once could raise on a vision and early traction now face pressure to demonstrate retention, margins, and operational maturity. In many cases, the market is rewarding those who can grow without continuously returning to investors, or who can show that each incremental dollar invested produces measurable, near-term outcomes.
The renewed focus on fundamentals is also reshaping what “innovation” looks like in pitch meetings. Rather than emphasizing only novelty, founders are being pushed to articulate why customers will pay, how distribution scales, and what makes the business hard to displace. In AI, this has encouraged a move away from thin wrappers and toward applications embedded in workflows where switching costs are meaningful, compliance is complex, or where outcomes can be contractually tied to performance. In fintech, it has renewed attention on risk management and regulatory capability as core competencies rather than afterthoughts.
Meanwhile, deeptech’s halo effect carries its own risks. If capital crowds too quickly into a subset of themes, valuations can detach from realistic milestones, particularly when technical validation is hard for outsiders to assess. That can set the stage for a future correction, especially in subfields where commercialization timelines are underestimated. In that sense, the question posed by VC Cafe serves as a caution as much as a diagnosis: deeptech is not a guaranteed refuge from the discipline now being applied across venture markets.
Still, the current moment suggests a clearer hierarchy of what investors are willing to back. Businesses promising fast growth without clear profit pathways are facing resistance. Those offering defensible technology, credible differentiation, and alignment with structural demand drivers have a stronger chance of attracting funding, even if they require patience. The market’s recalibration, as reflected in “Is anything fundable anymore apart from deeptech?” on VC Cafe, is less about narrowing the definition of venture and more about renewing it: capital is being priced again around risk, time, and the plausibility of building something that lasts.
